Mesenchymal stem cells overexpressing Sirt1 inhibit prostate cancer growth by recruiting natural killer cells and macrophages

Prostate cancer (PCa) has become the second leading cause of male cancer-related mortality in the United States. Mesenchymal stem cells (MSCs) are able to migrate to tumor tissues, and are thus considered to be novel antitumor carriers. However, due to their immunosuppressive nature, the application...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Autores principales: Yu, Yang, Zhang, Qingyun, Meng, Qinggui, Zong, Chen, Liang, Lei, Yang, Xue, Lin, Rui, Liu, Yan, Zhou, Yang, Zhang, Hongxiang, Hou, Xiaojuan, Han, Zhipeng, Cheng, Jiwen
Formato: Artigo
Lenguaje:Inglês
Publicado: Impact Journals LLC 2016
Materias:
Research Paper: Immunology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342066/
https://ncbi.nlm.nih.gov/pubmed/27764779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12737
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares